Back
KraneShares Emerging Markets Consumer Tech Idx ETF Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Buy
81
KEMQ
KraneShares Emerging Markets Consumer Tech Idx ETF
Last Price:
$22.35
Seasonality Move:
-4.95%
Sell
43
REGN
Regeneron Pharmaceuticals
Last Price:
$547.36
Seasonality Move:
8.46%
Buy
81
KraneShares Emerging Markets Consumer Tech Idx ETF (KEMQ)
is a Buy
Is KraneShares Emerging Markets Consumer Tech Idx ETF a Buy, Sell or Hold?
-
The current KraneShares Emerging Markets Consumer Tech Idx ETF [KEMQ] share price is $22.23. The Score for KEMQ is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
-
KEMQ is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
43
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals [REGN] share price is $547.74. The Score for REGN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KEMQ Stock Price Chart
What is KraneShares Emerging Markets Consumer Tech Idx ETF's stock price today?
-
The KraneShares Emerging Markets Consumer Tech Idx ETF share price today is $22.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KEMQ is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $547.74The current trend is relatively stagnant and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
KEMQ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.12 | Buy |
Relative Strength Index (14 RSI): | 63.94 | Buy |
Chaikin Money Flow: | 5576 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.6 - 22.2) | Buy |
Bollinger Bands (100): | (18.28 - 21.04) | Buy |
REGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.2 | Sell |
Relative Strength Index (14 RSI): | 56.59 | Buy |
Chaikin Money Flow: | 536070 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (491.6 - 548.18) | Buy |
Bollinger Bands (100): | (533.32 - 670.38) | Sell |
KEMQ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.33 | Sell |
20-day SMA: | 21.71 | Buy |
50-day SMA: | 20.43 | Buy |
200-day SMA: | 18.63 | Buy |
8-day EMA: | 22.08 | Buy |
20-day EMA: | 19.01 | Buy |
50-day EMA: | 12.02 | Buy |
200-day EMA: | 3.94 | Buy |
REGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 525.52 | Buy |
20-day SMA: | 516.55 | Buy |
50-day SMA: | 553.01 | Sell |
200-day SMA: | 724.22 | Sell |
8-day EMA: | 528.81 | Buy |
20-day EMA: | 527.99 | Buy |
50-day EMA: | 551.78 | Sell |
200-day EMA: | 692.17 | Sell |
KraneShares Emerging Markets Consumer Tech Idx ETF Earnings Growth & KEMQ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.42 per share, a decrease next quarter of $0.05 per share, a decrease this year of $9.47 per share, and an increase next year of $4.28 per share.
KraneShares Emerging Markets Consumer Tech Idx ETF Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regeneron Pharmaceuticals Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |